NOVAVAX INC — Director's Dealing 2022

Mar 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2022-03-10

Reporting Person: Erck Stanley C (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-10	Stock Option (Right to Buy)	$77.77	A	62211	Acquired	2032-03-10	Common Stock (62211)	Direct
2022-03-10	Restricted Stock Units	$	A	41474	Acquired		Common Stock (41474)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 10, 2022 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.